Robotimize seals rehab partnership at Medical Fair Asia 2026

Robotimize Group used Medical Fair Asia 2026 in Singapore to deepen regional partnerships, including a memorandum with St Luke’s Hospital for a technology-enabled rehabilitation centre. The event also featured a leadership forum on why promising rehab tech often fails to move from pilots into routine care.

Why it matters: - Robotimize is positioning itself as a regional rehabilitation technology partner, not just a product vendor. - The St Luke’s Hospital agreement could shape how technology is used across day rehabilitation, frailty care, neurological conditions and post-acute recovery. - The forum discussion underscored a broader challenge in healthcare: strong clinical technology still needs workable workflows, staffing and incentives to reach routine use.

What happened: - Robotimize Group spent three days meeting partners and collaborators at Medical Fair Asia 2026 at Marina Bay Sands in Singapore. - The event drew more than 1,000 exhibitors from about 40 countries and regions. - Robotimize signed a Memorandum of Understanding with St Luke’s Hospital to advance a technology-enabled Rehabilitation Centre of Excellence. - Robotimize also took part in the MotusAcademy × REHACARE Asia Leadership Forum, titled “From Pilot to Practice: Closing Asia’s Rehabilitation Technology Adoption Gap.” - Zen Koh, Scientific Advisor at Robotimize Group, chaired the forum.

The details: - Medical Fair Asia 2026 focused on hospital and clinical diagnostics, digital health, software as a medical device and medical technology for clinical decision-making. - The event banner was “Where Healthcare’s Ecosystem Comes Together.” - The exhibition highlighted pressures from ageing populations, healthcare workforce constraints and the shift of care beyond the traditional hospital setting. - The Robotimize-St Luke’s Hospital MOU covers day rehabilitation, gym-based programmes, frailty, neurological conditions and post-acute deconditioning. - The agreement is intended to build capability and support technology adoption across multiple rehabilitation areas over time. - The leadership forum brought together clinical, health-system, research, community and innovation perspectives. - Zen Koh said successful adoption is not a technology problem alone, and a device can fail to become routine care if workflows, workforce, incentives and service models do not work. - Robotimize said the company met existing and prospective partners across the region during the exhibition and forum. - Robotimize said conversations at the event are expected to inform future collaborations in the months ahead. - The company said the setting mattered because it brought manufacturing, procurement and long-term care stakeholders together in one place for three days. - Robotimize is headquartered in Singapore and focuses on intelligent rehabilitation robotics and digital neurotechnologies. - The company’s VivantePlexus™ ecosystem and ACE™ partnerships portfolio support clinician-led rehabilitation, functional training and technology-enabled care pathways across institutional and community settings. - Product availability, indications and use depend on applicable regulatory approvals and local clinical requirements. - More information is available in the company’s announcement.

Between the lines: - Robotimize is signaling that rehabilitation adoption depends on system design as much as device performance. - The company’s emphasis on partnerships suggests a long-term market strategy built around integration into care pathways, not one-off sales. - Singapore’s role as a regional hub gave Robotimize access to a dense mix of healthcare decision-makers in one venue. - The MOU and the forum appear to reinforce each other: one points to implementation, the other explains why implementation is hard.

What's next: - Robotimize expects the meetings and forum discussions to shape its regional collaboration plans over the coming months. - Work with St Luke’s Hospital is set to continue under the new memorandum. - Robotimize said it will keep working with healthcare providers, researchers and industry partners across the region.